ADVFN UK Market News

Category: Market News

  • European equities retreat as Middle East tensions flare and AI concerns weigh on sentiment: DAX, CAC, FTSE100

    European equities retreat as Middle East tensions flare and AI concerns weigh on sentiment: DAX, CAC, FTSE100

    European stock markets traded lower on Monday, while oil prices surged, after renewed hostilities between Iran and Israel raised fears over the durability of a U.S.-brokered ceasefire and added fresh uncertainty to global markets.

    By 03:03 ET (07:03 GMT), the pan-European Stoxx 600 had fallen 0.9%. Germany’s DAX dropped 1.3%, France’s CAC 40 declined 0.9%, and the FTSE 100 slipped 0.4%.

    The latest escalation marked the first direct exchange of attacks between Iran and Israel since a fragile truce came into force in April.

    According to media reports, the confrontation was triggered by an Israeli strike on Beirut, the Lebanese capital. Israel has continued to confront Iran-backed Hezbollah forces in Lebanon, although recent clashes had remained relatively contained. Tehran subsequently launched retaliatory attacks, prompting further Israeli military action targeting sites in central and western Iran.

    Israel said on Monday that warning sirens had been activated in response to additional attacks originating from Iran. The country also reported intercepting a ballistic missile fired from Yemen, according to the Wall Street Journal. The newspaper also cited Iran’s Islamic Revolutionary Guard Corps as saying it had targeted airbases in southern Israel.

    Despite the renewed violence, U.S. President Donald Trump said the developments would not derail Washington’s efforts to secure a broader peace agreement with Iran. However, an Iranian official told MS NOW that such a deal is “no longer feasible at this stage.”

    Oil markets reacted sharply to the geopolitical developments. Brent crude, the international benchmark, rose 5.1% to $97.81 per barrel. Although prices remain below previous peaks above $100 per barrel, they are still significantly higher than levels seen before the conflict intensified.

    The rise in energy prices has fuelled concerns that inflationary pressures could re-emerge, potentially prompting central banks, including the European Central Bank, to tighten monetary policy further.

    Government bond yields across the eurozone climbed to multi-week highs, adding pressure to equity markets. Investors are now pricing in as many as three ECB interest rate increases before the end of the year. Bond yields move inversely to prices.

    Beyond geopolitical risks, investors are also reassessing expectations surrounding the artificial intelligence sector. Sentiment weakened following disappointing quarterly results from chipmaker Broadcom (NASDAQ:AVGO) last week, raising questions about the sustainability of the AI-driven market rally.

    A stronger-than-expected U.S. employment report released on Friday further reinforced expectations that the Federal Reserve could maintain a tighter policy stance into 2026.

    European semiconductor stocks moved lower in early trading, reflecting weakness across technology shares in Asia and extending the decline seen on Wall Street at the end of last week.

  • FTSE 100 falls as renewed Iran-Israel conflict sparks flight from risk assets

    FTSE 100 falls as renewed Iran-Israel conflict sparks flight from risk assets

    UK equities opened lower on Monday as investors reacted to a sharp escalation in tensions between Iran and Israel, prompting a move away from risk-sensitive assets and driving energy prices sharply higher.

    The FTSE 100 was down 0.27% in early trading, while losses across continental Europe were more pronounced. Germany’s DAX declined 1.16% and France’s CAC 40 fell 0.86% as markets assessed the implications of the latest military developments in the Middle East.

    Sterling eased marginally against the U.S. dollar, slipping 0.01% to 1.3340. Oil prices surged amid concerns over regional stability and potential supply disruptions. Brent crude rose 4.84% to $97.57 a barrel, while West Texas Intermediate gained 4.42% to $94.54.

    The sell-off followed direct military exchanges between Israel and Iran, marking the most significant escalation since the ceasefire agreed in April. Israeli forces reportedly carried out strikes against military-related targets in western and central Iran, including facilities linked to the Karoun petrochemical complex in Mahshahr.

    Iran responded through the Islamic Revolutionary Guard Corps, which said it had targeted Israeli air bases at Nevatim and Tel Nof as part of what it called Operation Nasr. Further missile launches towards Israel were reported on Monday morning, triggering air raid warnings across Tel Aviv and central parts of the country.

    The situation broadened further as Yemen’s Houthi movement launched additional attacks against Israel and announced a complete ban on Israeli-linked maritime navigation in the Red Sea. Meanwhile, Iran suspended civilian flights at several major airports, and reports indicated widespread internet disruptions across parts of the country.

    Market participants are also closely monitoring developments around the Strait of Hormuz, a key global energy transit route. Iranian officials indicated that future access arrangements could be subject to revised conditions, adding to concerns over potential disruptions to oil shipments.

    Diplomatic efforts continued behind the scenes, with U.S. President Donald Trump reportedly urging restraint in discussions with Israeli Prime Minister Benjamin Netanyahu. However, rhetoric from regional leaders remained confrontational, increasing uncertainty over the direction of the conflict.

    Separately, OPEC+ agreed over the weekend to increase production quotas by 188,000 barrels per day in July in an effort to help stabilise energy markets.

    UK corporate highlights

    Tate & Lyle agrees £2.7 billion takeover offer

    Tate & Lyle (LSE:TATE) announced it has agreed to a £2.7 billion cash acquisition by U.S. ingredients group Ingredion, with shareholders set to receive a substantial premium to the pre-offer share price.

    Debenhams expands into beauty through Revolution partnership

    Debenhams Group (LSE:DEBS) has entered into a licensing agreement with Revolution Beauty (LSE:REVB) to develop fragrance and beauty products under several of its fashion and lifestyle brands, extending its presence into higher-growth consumer categories.

  • Tate & Lyle agrees £2.7 billion cash takeover by Ingredion as shares rally (TATE)

    Tate & Lyle agrees £2.7 billion cash takeover by Ingredion as shares rally (TATE)

    Tate & Lyle Plc (LSE:TATE) shares surged more than 12% after U.S.-based ingredients company Ingredion Incorporated reached an agreement to acquire the British food ingredients and solutions group in a cash transaction valued at approximately £2.7 billion.

    Under the terms of the recommended deal, Tate & Lyle shareholders will receive 595 pence per share in cash. They will also be entitled to a final dividend of up to 13.2 pence per share for the financial year ended 31 March 2026 and an interim dividend of up to 6.8 pence per share for the six months ending 30 September 2026. Including these permitted dividends, the total value of the offer rises to as much as 615 pence per share.

    The cash offer represents a premium of 58.7% to Tate & Lyle’s closing share price on 13 May 2026, the last trading day before the offer period commenced, and a 65.2% premium to the company’s three-month volume-weighted average share price at that date. Including the permitted dividends, the premium increases to 64.0% and 70.8% respectively.

    The transaction values Tate & Lyle at an enterprise value of approximately £3.7 billion based on the cash consideration alone, increasing to around £3.8 billion if the dividends are paid in full. The valuation equates to roughly 8.8 times adjusted EBITDA for the 12 months ended 31 March 2026, before taking account of any anticipated synergies.

    Ingredion’s pursuit of Tate & Lyle followed a five-stage negotiation process that began with an unsolicited proposal of 530 pence per share, structured as 80% cash and 20% Ingredion stock. The Tate & Lyle board rejected that approach, prompting four further proposals before the parties reached agreement on an all-cash offer.

    The combined business is expected to generate approximately $9.9 billion in annual revenue and around $1.8 billion in adjusted EBITDA. Ingredion expects to achieve run-rate net cost synergies of approximately $130 million annually by the end of 2030, with one-off implementation costs estimated at around $175 million.

    David Hearn, chairman of Tate & Lyle, said the board believes “Ingredion’s offer represents an attractive opportunity for shareholders to crystallise value in cash.”

    Support for the transaction has already been secured through irrevocable undertakings covering 76,186,458 shares, representing approximately 17.1% of Tate & Lyle’s issued share capital as of 5 June 2026. This includes the commitment of Huber Equity Corporation, which owns 75 million shares, equivalent to roughly 16.8% of the company.

    Completion of the acquisition remains subject to shareholder approval and regulatory clearances across 12 competition jurisdictions, including the United States, European Union, United Kingdom, China and Brazil. The long-stop date for completion has been set at 8 December 2027.

    More about Tate & Lyle

    Tate & Lyle Plc is a global provider of food and beverage ingredients and solutions, serving customers across a wide range of consumer markets. The company specialises in sweeteners, texturants, fibres and speciality ingredients that help manufacturers improve the nutritional profile, taste and functionality of food and drink products. Through its science-led approach, Tate & Lyle supports customers worldwide in developing healthier and more sustainable products.

  • Audioboom abandons sale process as record first-half performance strengthens independent outlook (BOOM)

    Audioboom abandons sale process as record first-half performance strengthens independent outlook (BOOM)

    Audioboom (LSE:BOOM) has concluded its strategic review and ended discussions regarding a potential sale of the business after determining that proposals received during the process did not adequately reflect the company’s value and growth prospects.

    The board said it received three non-binding cash offers, each at a premium to the share price prior to the launch of the review. However, after evaluating the proposals, directors decided not to pursue a transaction. With no active takeover discussions continuing, Audioboom has exited its offer period and is no longer subject to the enhanced disclosure requirements associated with a potential acquisition process.

    Management said the decision reflects growing confidence in the company’s standalone strategy, supported by continued operational momentum and improving financial performance.

    Trading has remained strong since the start of the year, with the positive trends reported in the first quarter extending into the second quarter. Audioboom now expects to deliver record results for the six months ending 30 June 2026, forecasting revenue of at least $45 million and adjusted EBITDA of no less than $3 million. Both figures are expected to be substantially ahead of the corresponding period last year.

    The upgraded outlook highlights the company’s continued expansion within the podcast advertising market, where increasing audience engagement and advertising demand are supporting growth. Management believes the performance provides reassurance to shareholders that the business can continue to create value independently following the conclusion of the strategic review.

    Audioboom’s outlook reflects a combination of improving profitability and a relatively low-debt balance sheet. However, negative operating and free cash flow reported during 2025 continue to weigh on overall financial quality. Technical indicators remain supportive, with the shares trading above key moving averages and demonstrating strong momentum, although some measures suggest the stock may be approaching overextended levels. Valuation remains reasonable based on earnings metrics, though the absence of a dividend limits income appeal.

    More about Audioboom

    Audioboom Group PLC is a global podcasting platform and one of the largest podcast publishers in both the United States and the United Kingdom. The company’s content reaches more than 50 million unique listeners each month and generates approximately 170 million downloads across its podcast network. Through its proprietary advertising and monetisation platform, Audioboom provides commercial, distribution, production and marketing services to podcast creators and advertisers across North America, Europe, Asia and Australia.

  • SkinBioTherapeutics restates FY25 accounts following investigation into former CEO conduct (SBTX)

    SkinBioTherapeutics restates FY25 accounts following investigation into former CEO conduct (SBTX)

    SkinBioTherapeutics (LSE:SBTX) has published unaudited interim results for the six months ended 31 December 2025, reporting revenue growth of 37.4% to £2.17 million while confirming a series of governance and accounting changes following an investigation into actions taken by its former chief executive.

    The increase in revenue was supported by a full six-month contribution from Bio-Tech Solutions, steady performance from the Dermatonics product range, the rollout of AxisBiotix products into more than 180 Superdrug stores and the receipt of initial licensing income. Gross margins remained broadly stable at approximately 56%, while operating losses narrowed modestly compared with the prior period.

    The company said trading in its AIM-listed shares will be restored following the publication of the results. Management is continuing to focus on expanding the Dermatonics brand, driving cost-effective growth for AxisBiotix, improving operational performance at Bio-Tech Solutions and advancing Zenakine, which recently received industry recognition.

    The reporting period was significantly impacted by the suspension and subsequent resignation of the former CEO after an independent investigation identified fabricated documentation that resulted in the incorrect recognition of approximately £0.77 million in accrued royalty revenue during FY25. The investigation, conducted by FRP Advisory, led to a restatement of FY25 revenue from £4.64 million to £3.87 million and an increase in the reported EBITDA loss.

    While investigators found no concerns relating to the company’s cash balances, the review identified weaknesses in governance processes and issues relating to the timing of bonus-related accounting. In response, SkinBioTherapeutics has implemented a number of corrective measures, including board changes, the repayment of certain bonus payments, enhanced financial controls and the appointment of a new audit firm.

    The company is also pursuing the recovery of approximately £0.7 million in investigation-related costs and is working to rebuild confidence among shareholders, commercial partners and other stakeholders following the findings of the review.

    Although revenue growth remains encouraging and the balance sheet is relatively conservative, the company’s outlook continues to be affected by ongoing losses and weak cash flow generation. Technical indicators also remain negative, with the shares trading below major moving averages and momentum measures remaining under pressure. Valuation support is limited due to the absence of profitability and dividend payments.

    More about SkinBioTherapeutics

    SkinBioTherapeutics is a UK-based life sciences company focused on developing and commercialising microbiome-based technologies for skin health and wellness applications. Its portfolio includes Dermatonics footcare products, AxisBiotix nutritional supplements for blemish-prone skin, Zenakine cosmetic ingredients and the Bio-Tech Solutions manufacturing and services business. The company distributes products through NHS channels, podiatry specialists and major high street retailers while continuing to expand its presence in the consumer health and beauty sectors.

  • KEFI advances Tulu Kapi development while expanding Saudi Arabian exploration footprint (KEFI)

    KEFI advances Tulu Kapi development while expanding Saudi Arabian exploration footprint (KEFI)

    KEFI (LSE:KEFI) has reported its 2025 results and confirmed that its flagship Tulu Kapi Gold Project in Ethiopia has entered the execution phase following the completion of a financing package worth more than $400 million.

    The company said the funding structure allows it to retain an expected beneficial interest of approximately 86% in the project. Development activities are already under way, including infrastructure works and community resettlement programmes, with a 27-month construction schedule having commenced in March 2026. First gold production remains targeted for mid-2028.

    Management believes Tulu Kapi has the potential to become Ethiopia’s largest single source of export revenue at current gold prices. The project is expected to produce an average of around 166,000 ounces of gold annually over an initial mine life of more than seven years. Expansion plans could increase output to approximately 200,000 ounces per year, while higher gold prices are expected to support strong project economics, significant EBITDA generation, accelerated debt reduction and substantial future cash flows.

    Alongside progress in Ethiopia, KEFI continues to strengthen its position in Saudi Arabia through its GMCO joint venture. The company said GMCO has assembled one of the country’s largest exploration portfolios and has been selected to participate in the Saudi government’s Exploration Enablement Program. The development reflects KEFI’s growing presence in a mining sector that is benefiting from regulatory reforms and increased government support.

    Despite the operational momentum, KEFI’s outlook remains constrained by the absence of revenue, continuing losses and ongoing cash burn. Technical indicators provide some encouragement, with the shares trading above key moving averages and supported by a positive MACD signal. However, valuation remains challenged by negative earnings and the lack of a dividend yield.

    More about KEFI Gold and Copper

    KEFI Gold and Copper is a mineral exploration and development company focused on gold and copper opportunities in Ethiopia and Saudi Arabia. The company has been active in both jurisdictions for more than two decades and aims to capitalise on increasing government support for the mining sector. Its portfolio includes the advanced-stage Tulu Kapi Gold Project in Ethiopia and a range of exploration interests in Saudi Arabia through its joint venture vehicle GMCO, which is partnered with local conglomerate ARTAR.

  • Aptamer joins Imperial College project to develop Gates-backed folic acid testing technology (APTA)

    Aptamer joins Imperial College project to develop Gates-backed folic acid testing technology (APTA)

    Aptamer Group (LSE:APTA) has begun a funded research collaboration with Imperial College London aimed at adapting its proprietary folic acid Optimer binders for use in rapid lateral flow tests designed to measure folate levels in fortified foods.

    The programme is supported by funding from the Gates Foundation and seeks to address the shortage of practical testing tools available for food fortification initiatives, particularly in lower-income countries. Such programmes are intended to reduce folic acid deficiency and help prevent associated birth defects, but often lack simple point-of-production methods for monitoring nutrient levels.

    As part of the collaboration, Aptamer will focus on developing sample preparation techniques suitable for field deployment and validating its folic acid Optimer binders by July 2026. Once validated, the binders will be supplied to Imperial College for integration into lateral flow testing devices, with field trials and validation work expected to be completed by the end of 2026.

    The company has structured the agreement to create potential long-term commercial opportunities. Aptamer expects to benefit from a future licensing arrangement for the technology while also supplying Optimer binders for device manufacturing. Importantly, the group will retain ownership of its underlying intellectual property, preserving the potential for future applications and recurring revenue streams.

    Management believes the collaboration could strengthen Aptamer’s position in the global diagnostics market while demonstrating the versatility of its Optimer technology in addressing public health challenges.

    Despite the strategic potential of the project, Aptamer’s outlook remains constrained by weak financial performance, including a significant decline in revenue, ongoing losses and negative cash flow. Technical indicators also remain under pressure, with the shares trading below major moving averages and momentum measures remaining weak despite signs of oversold conditions. Valuation support remains limited due to negative earnings and the absence of a dividend.

    More about Aptamer Group Plc

    Aptamer Group plc is a life sciences company focused on the development of synthetic affinity binders known as Optimers. These proprietary molecules are designed for use across diagnostics, therapeutics and research applications, offering an alternative to traditional antibodies. The company works with academic and commercial partners to incorporate its Optimer technology into diagnostic assays, lateral flow devices and other analytical platforms.

  • Mpac to divest Lambert business for up to £20 million as trading outlook softens (MPAC)

    Mpac to divest Lambert business for up to £20 million as trading outlook softens (MPAC)

    Mpac Group (LSE:MPAC) has announced the sale of its bespoke automation division, Mpac Lambert, including the SIGA Vision business, to Italy-based Mech.i. Tronic S.p.A. in a transaction valued at up to £20 million, while also warning that earnings for 2026 are expected to fall materially short of market forecasts.

    The company said first-half margins are likely to be lower than those achieved in the corresponding period last year, reflecting a combination of delayed customer investment decisions, increased pricing pressure and reduced operational leverage. As a result, management expects underlying profit before tax for 2026 to be substantially below current market expectations.

    To address the more challenging trading environment, Mpac has implemented additional measures aimed at improving efficiency and cash generation. These include actions to increase volumes, reduce overhead costs, align manufacturing capacity with demand levels and preserve liquidity. The company reported an order book of £98.8 million and said maintaining covenant headroom and strengthening cash flow remain key priorities.

    Alongside these operational initiatives, Mpac has agreed to dispose of Mpac Lambert as part of a broader strategic focus on scalable, full-line packaging machinery solutions. The transaction includes an initial consideration of £16 million, with up to a further £4 million payable through earn-out arrangements, subject to regulatory approvals and other completion conditions.

    Management expects the proceeds to significantly reduce net debt, which stood at £47.9 million, while sharpening the group’s strategic focus on its core packaging automation activities. The company believes the disposal will leave the business better positioned to benefit when customer investment activity recovers.

    Mpac’s outlook remains challenged by weaker financial performance, including a net loss reported in 2025, negative operating and free cash flow, and higher leverage levels. Technical indicators also remain unfavourable, with the shares trading below key moving averages and momentum measures remaining weak. Valuation support is limited as earnings remain under pressure and the company does not currently offer a dividend yield.

    More about Mpac Group PLC

    Mpac Group plc is a global provider of high-speed packaging and automation solutions, designing and manufacturing precision machinery, production systems and end-of-line packaging equipment. Headquartered in Coventry, the company serves customers in the food, beverage and healthcare sectors across more than 80 countries through a portfolio of brands that includes BCA, Langen, Switchback and CSi. The group combines equipment sales with recurring service and support activities to provide integrated automation solutions worldwide.

  • Pharos Energy brings Egyptian receivables fully up to date and resumes drilling activity (PHAR)

    Pharos Energy brings Egyptian receivables fully up to date and resumes drilling activity (PHAR)

    Pharos Energy (LSE:PHAR) has eliminated all outstanding receivables relating to its Egyptian operations after receiving $12.6 million in payments during 2026, in addition to a $20 million payment received at the end of 2025.

    The milestone leaves the company’s Egyptian receivables position fully current for the first time since it acquired the assets in 2019. Management attributed the improvement to ongoing engagement with Egyptian authorities and the introduction of a strengthened fiscal framework under a new consolidated concession agreement. Pharos also confirmed that it has received all contingent payments associated with its previous farm-out arrangement with IPR.

    With the payment backlog resolved, the company has restarted drilling operations in Egypt as part of a six-well campaign designed to support future production and development objectives. The first well in the programme, Silah 8-2, was spudded on 4 June 2026.

    Pharos plans to invest approximately $11 million in capital expenditure as it seeks to unlock additional value from its Egyptian asset portfolio. Management believes the combination of improved payment discipline and renewed operational activity strengthens the company’s financial position and creates a more supportive environment for investment and production growth.

    The company’s outlook continues to benefit from a strong balance sheet, minimal leverage and healthy free cash flow generation. Technical indicators also remain broadly supportive, reflecting a positive longer-term trend. These strengths are partly offset by fluctuations in profitability and revenue, while a negative price-to-earnings ratio highlights ongoing earnings volatility despite the support of a dividend yield.

    More about Pharos Energy

    Pharos Energy plc is an independent oil and gas company with a portfolio of production, development and exploration assets in Vietnam and Egypt. Listed on the Main Market of the London Stock Exchange, the company focuses on sustainable growth through disciplined capital allocation, cash-generative operations and opportunities for both organic development and strategic expansion.

  • Neo Energy Metals suspends CFO pending investigation while reaffirming financial position (NEO)

    Neo Energy Metals suspends CFO pending investigation while reaffirming financial position (NEO)

    Neo Energy Metals (LSE:NEO) has suspended Chief Financial Officer De Wet Schutte as the company conducts an investigation into potential misconduct, while emphasising that the matter does not relate to financial mismanagement and has no impact on the group’s financial position.

    The company said the investigation is ongoing and that further updates will be provided when appropriate. To ensure continuity during the process, the board has appointed Martin Westerman to oversee the finance function and maintain day-to-day financial operations.

    Management stressed that the suspension does not affect the company’s financial stability or operational activities. The move reflects the board’s commitment to maintaining strong governance standards and ensuring appropriate oversight while the matter is reviewed.

    The announcement comes as Neo Energy Metals continues to advance its growth strategy in South Africa. The company has established a significant uranium and gold resource base through its two flagship uranium projects and is pursuing an additional listing on the Johannesburg Stock Exchange Main Board in 2026 to broaden its access to capital markets and expand its investor base.

    The board believes the steps taken will help preserve operational continuity and governance integrity while the investigation is completed.

    More about Neo Energy Metals

    Neo Energy Metals is a South Africa-focused uranium and gold development company listed on the London Stock Exchange’s Main Market and the A2X exchange. The company is targeting a further listing on the JSE Main Board in 2026 and holds two South African uranium projects containing a combined JORC- and SAMREC-compliant resource of approximately 31.5 million pounds of uranium and 1.2 million ounces of gold.